IOL

Visual outcomes after secondary IOL implantation in aphakic children

According to physicians, patients who do not undergo second procedure are more likely to develop glaucoma.

Harrow and iOR Partners expand national product supply agreement

The deal will provide Harrow’s entire formulary compounded ophthalmic products to iOR Partners’ expanding office-based surgery locations across the United States.

Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future

In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.

Alcon completes acquisition of Aerie Pharmaceuticals

November 22, 2022

The deal adds pharmaceutical research and development capabilities and further expertise for future product pipeline. It also expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category.

Boarding Orbis Flying Eye Hospital: Not your typical flight experience

November 16, 2022

When it is not on a mission, the Orbis Flying Eye Hospital MD-10 aircraft often is situated at an airport where the fully accredited teaching facility is put to use as a mobile simulation center to train ophthalmologists from around the world in some of the latest sight-saving techniques.

Private practice vs academics: What do young ophthalmologists need to know?

November 02, 2022

Nicole Bajic, MD, and Neel S. Vaidya, MD, MPH, share their insights from when they were at this crossroads. Learn more clinical pearls on topics like this and more at Real World Ophthalmology’s virtual conference, “Top 10 Things I Wish I Knew Sooner,” this Saturday, November 5.